Toripalimab Uses, Dosage, Side Effects and more
Toripalimab is under investigation in clinical trial NCT03919383 (Phase II of Lenvatinib Plus Toripalimab for Advanced HCC).
| Trade Name | Toripalimab |
| Generic | Toripalimab |
| Toripalimab Other Names | Toripalimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
